≥99% HPLC verified · 3 sizes available
Triple agonist (GLP-1 / GIP / glucagon receptor) studied in metabolic pathway research.
Size
Synthetic compound
Defined synthetic material for controlled laboratory research and analytical method development.
In the literature
Cited across published research on peptide stability, receptor interaction, and biological signaling.
Lab settings
Examined in vitro and in preclinical models. Studies focus on molecular properties under controlled systems.
Non-therapeutic
For laboratory research only. Not approved for human consumption, treatment, or therapeutic application.
GLP-3 (RT) is a synthetic peptide engineered as a triple receptor agonist, with binding affinity for GLP-1, GIP, and glucagon receptors. The triple-receptor mechanism represents the newest characterized class in incretin pathway research literature, with studies investigating multi-receptor signaling, glucose-substrate regulation, and metabolic pathway modeling.
Each Perplexa lot is independently verified by HPLC purity analysis with identity confirmed by mass spectrometry. The lot-specific Certificate of Analysis is published on this product page before the lot ships, including chromatograms, MS reports, and identity verification. The 60MG variant ships in a 10mL vial; the 10MG and 30MG variants ship in standard 3mL vials.
This material is supplied for in vitro research only. It is not a drug, supplement, food, or cosmetic, and is not for human or veterinary consumption.
This material is supplied for in vitro research only. It is not a drug, supplement, food, or cosmetic, and is not for human or veterinary consumption.
| Form | Lyophilized powder |
| Purity | ≥99% (HPLC) |
| Size | 30MG |
| Vial | 3mL |
| Storage | -20°C, desiccated, protected from light |
| Origin | USA |
| Appearance | White lyophilized powder |
| Solubility | Soluble in bacteriostatic water, sterile saline |
| Mol. Weight | # |
| Stability | 24 months at -20°C |
| Identity | Mass spectrometry |
Reconstitution, storage, and handling are the responsibility of the qualified researcher.Perplexa Labs does not provide protocols, dosing guidance, or human-use instructions.